GNS Partners with NCI on Personalized Treatment of NSCLC

GNS will use its REFS platform to analyze data from NCI in the hopes of identifying biomarkers that can help guide treatments for NSCLC patients.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories